Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global tumor ablation market report, please download the report brochure.
In this market, microwave ablation is the largest technology segment of tumor ablation, whereas surgical ablation is the largest mode of treatment. Growth in various segments of the tumor ablation market are given below:
The study includes trends and forecast for the global tumor ablation market by technology, application, mode of treatment, end user, and region as follows:
- Radiofrequency (RF) Ablation
- Microwave Ablation
- Cryo Ablation
- Other Technologies
By Application [$M shipment analysis for 2014 – 2025]:
- Liver
- Lung
- Kidney
- Bone Metastasis
- Prostate
- Breast
By Mode of Treatment [$M shipment analysis for 2014 – 2025]:
- Percutaneous Ablation
- Laparoscopic Ablation
- Surgical Ablation
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Others
By End User [$M shipment analysis for 2014 – 2025]:
- Hospitals
- Oncology Clinics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Spain
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Lucintel forecasts that microwave ablation will remain the largest technology segment over the forecast period due to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.
Within this market, surgical ablation will remain the largest mode of treatment segment over the forecast period due to a large number of minimally invasive surgical procedures performed in mature markets to treat various cancers, growing market awareness of the benefits of surgical ablation in emerging markets, and large proportion of cancer patients ineligible for surgical cancer treatment.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to rising inclination of patients towards minimally invasive procedures for cancer treatment and increasing government funding for cancer research.
|
Features of the Global Tumor Ablation Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global tumor ablation market by technology (radiofrequency (RF) ablation, microwave ablation, cryo ablation and others), application (liver, lung, kidney, bone metastasis, prostate, and breast), mode of treatment (percutaneous ablation, laparoscopic ablation, surgical ablation, liver cancer, lung cancer, kidney cancer, bone metastasis and others), end user (hospitals and oncology clinics), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global tumor ablation market? Q.5 What are the business risks and threats to the global tumor ablation market? Q.6 What are the emerging trends in this tumor ablation market and the reasons behind them? Q.7 What are some changing demands of customers in this tumor ablation market? Q.8 What are the new developments in this tumor ablation market? Which companies are leading these developments? Q.9 Who are the major players in this tumor ablation market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this tumor ablation market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global tumor ablation market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Technology (Radiofrequency (RF) Ablation, Microwave Ablation, Cryo Ablation and Others), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, and Breast), Mode Of Treatment (Percutaneous Ablation, Laparoscopic Ablation, Surgical Ablation, Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis and Others), and End User (Hospitals and Oncology Clinics) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.